Background: Heart valve replacement has many complications that affect patients and their family caregivers. Increasing patients' self-efficacy in dealing with complications and reducing the care burden of their caregivers are among the critical factors that impact their quality of life. Today, smartphone Apps allow access to reliable information without time and place restrictions. It also facilitates teaching and learning through low-cost and easily accessible methods.
Objective: This study was conducted to examine the effect of a smartphone App on the care burden of family caregivers and self-efficacy of patients undergoing heart valve surgery.
Methodology: A randomized clinical trial study with a pre-test / post-test design was conducted. Sixty patients undergoing mechanical heart valve surgery were referred to the Shahid Modarres Hospital and PT clinic in Tehran, and their family caregivers were randomly divided into intervention and control groups. The App was installed on the patients' smartphones for educational purposes, and they were given 8 weeks to use it. Sullivan's cardiac self-efficacy questionnaire and Novak and Guest's care burden questionnaire were completed for patients and their caregivers in both groups before and after the intervention, respectively. Data was statistically analyzed using descriptive and inferential statistics through SPSS-18 software.
Findings: There was no statistically significant difference between the two groups regarding demographic characteristics and the mean scores of self-efficacy and care burden before the intervention. However, after the intervention, the mean self-efficacy score increased to 47.43 ± 5.43 in the intervention group and 32.23 ± 3.25 in the control group, showing a significant improvement in patients' self-efficacy in the intervention group (P < 0.001). Although the mean self-efficacy score slightly increased in the control group, this increase was not statistically significant (P = 0.094). Furthermore, the mean score of care burden of caregivers after the intervention increased to 45.33 ± 6.34 in the intervention group and 53.86 ± 6.80 in the control group, showing a significant decrease in the care burden of caregivers in the intervention group compared to those in the control group (P < 0.001).
Conclusion: Based on the results, the designed smartphone App improved the self-efficacy of patients undergoing heart valve surgery while reducing the care burden of their family caregivers. Therefore, this App is recommended due to its effectiveness, ease of use, and low cost.
Trial Registration: Prospectively registered with the Iranian Registry of Clinical Trials on 11 March 2023; registration code: IRCT20210714051889N1.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1186/s12912-025-02909-0 | DOI Listing |
Arterioscler Thromb Vasc Biol
March 2025
Department of Pediatrics, Division of Pediatric Cardiology, Medical College of Wisconsin, Milwaukee (T.B., J.R.K., A.J.K., J.L.).
Background: Heart valve function requires a highly organized ECM (extracellular matrix) network that provides the necessary biomechanical properties needed to withstand pressure changes during each cardiac cycle. Lay down of the valve ECM begins during embryogenesis and continues throughout postnatal stages when it is remodeled into stratified layers and arranged according to blood flow. Alterations in this process can lead to dysfunction and, if left untreated, heart failure.
View Article and Find Full Text PDFCureus
March 2025
Division of Cardiac Surgery, University Hospital Center "Mother Teresa", Tirana, ALB.
Background Tricuspid valve regurgitation is frequently overlooked by cardiologists and cardiac surgeons alike; consequently, the tricuspid valve is often referred to as "the forgotten" valve. It is the most common complication of left heart valve disease. Ring annuloplasty and suture (De Vega) annuloplasty represent two common surgical treatment techniques.
View Article and Find Full Text PDFCureus
February 2025
Cardiovascular Disease, University of Florida Health, Jacksonville, USA.
Transcatheter aortic valve implantation (TAVI) has significantly improved in treating aortic valve disease in recent years, particularly in patients at high surgical risk. This case report describes an 80-year-old woman who had severe aortic stenosis previously treated with surgical aortic valve replacement (SAVR) and six years later had a valve-in-valve (ViV) TAVI who developed severe symptomatic restenosis of the bioprosthetic aortic valve five years later of the last procedure. A third valve-in-valve-in-valve (ViViV) TAVI using a 26-mm Sapien 3 valve was performed due to the high surgical risk.
View Article and Find Full Text PDFKardiol Pol
March 2025
Clinical Department of Interventional Cardiology, St. John Paul II Hospital, Kraków, Poland.
Int J Mol Sci
February 2025
Neonatal Congenital Heart Laboratory, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
One out of every hundred live births present with congenital heart abnormalities caused by the aberrant development of the embryonic cardiovascular system. The conserved zinc finger transcription factor proteins, which include GATA binding protein 5 (GATA5) and GATA binding protein (GATA6) play important roles in embryonic development and their inactivation may result in congenital heart defects (CHDs). In this study, we performed genotypic-phenotypic analyses in two families affected by right-sided CHD diagnosed by echocardiography imaging.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!